학술논문

1052PD - Nivolumab (N) (Anti-Pd-1; Bms-936558, Ono-4538) in Combination with Sunitinib (S) or Pazopanib (P) in Patients (Pts) with Metastatic Renal Cell Carcinoma (Mrcc)
Document Type
Abstract
Source
In Annals of Oncology September 2014 25 Supplement 4:iv362-iv362
Subject
Language
ISSN
0923-7534